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CytoskeletonCytoskeletal remodeling is responsible for cell plasticity and facilitates differentiation, motility and adherence
related functions. C3G (RAPGEF1), an exchange factor for Ras family of small GTPases, regulates cytoskeletal
reorganization to induce ﬁlopodia in epithelial cells and neurite growth in neuroblastoma cells. Here we show
that C3G overexpression induces neurite-like extensions (NLE) in MDA-MB-231 and BT549 breast carcinoma
cells and not in a variety of other cancer cell lines examined. These processes were actin-rich with nodes,
branches and microspikes. C3G associates with the cytoskeleton and its expression enabled stabilization of
microtubules. NLE formation was dependent on Rap, Rac and Cdc42. C3G expression was associated with a
decrease in cellular β-catenin levels speciﬁcally in MDA-MB-231 and BT549 cells. β-Catenin stabilization
induced by GSK-3β inhibition, or coexpression of β-catenin, reduced C3G induced NLE formation. Time lapse
analysis showed reduced motility of C3G expressing cells compared to GFP expressing cells. Our results
suggest that C3G overexpression can induce phenotypic characteristics of neuronal cells in highly invasive
breast cancer cells and inhibit their motility.ctor; NLE, neurite-like exten-
Dn, dominant negative
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Cytoskeletal remodeling is responsible for maintenance of cell
shape, adhesion, motility and vesicular transport and its regulation is
important for cellular differentiation and tissue morphogenesis. The
metastatic potential of cancer cells is dependent on dynamic
rearrangements of the cytoskeleton and regulators of cytoskeleton
remodeling contribute to the aetiopathogenesis of malignancy [1]. In
response to extracellular stimuli a variety of regulatory molecules
signal to changes in the cytoskeleton [2]. Extensive reorganization of
the cytoskeleton occurs during neuronal differentiation and therefore
it has been important to elucidate the molecular effectors that bring
about these morphological changes that precede acquisition of
biochemical characteristics by mature neurons [3]. Small GTPases of
the Rho and Ras family have generally been implicated in signaling to
the cytoskeleton and their activity is triggered by guanine nucleotide
exchange factors (GEFs) that respond to stimuli received through
transmembrane receptors [4].
The GEF, C3G that activates Rap, R-Ras and TC10 GTPases has been
implicated in signaling pathways stimulated by growth factors,
cytokines, adhesion receptors and mechanical stress [5–12]. C3G has
a catalytic domain in its extreme C-terminus and a central regioncontaining multiple proline-rich sequences responsible for protein
interaction [13,14]. It interacts with Crk, p130 Cas, Hck and c-Abl and
its activity is known to be regulated through membrane recruitment
and tyrosine phosphorylation [13–19]. Tyrosine phosphorylated C3G
localizes to the Golgi and sub-cortical cytoskeleton [20]. It interacts
with E-cadherin through sequences in the N-terminal domain [21]. In
signaling pathways it appears to serve functions dependent on its
catalytic activity and/or through protein interactions. Regulation of
cell adhesion and migration, cell proliferation and cell death are some
of the functions attributed to C3G [11,16,22–24]. Cell and tissue
speciﬁc differences have been seen in the motility phenotype
exhibited upon C3G deregulation. While in some instances it enables
cell migration, in other cases it functions to inhibit motility [25–28]. It
has been shown to suppressmalignant transformation independent of
its catalytic activity [29]. Transformation suppression is mediated
through actin binding and PP2A activation at the sub-cortical actin
cytoskeleton [30]. Inactivation of C3G has been shown to be
associated with cervical squamous cell carcinomas [31].
We have recently demonstrated a role for C3G in signaling to actin
reorganization during ﬁlopodia formation in epithelial cells and neurite
growth in neuroblastoma cells [17,32]. C3G plays an essential role in
embryonic development as C3G knockoutmice show embryonic lethality
[33]. Fibroblasts from embryos lacking C3G show defective adhesion and
enhanced motility. Mice compromised for C3G expression due to
insertion of a hypomorphic allele have defects in multiple systems such
as vascular maturation and brain cortical development [34,35]. Our
ﬁnding that C3G overexpression can induce morphological changes and
neurite growth in neuroblastoma cells lead us to investigate the effect of
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cells. Here we show that C3G expression can induce the formation of
neurite-like extensions (NLEs) speciﬁcally in aggressive breast cancer
cells. Some molecular events involved downstream of C3G to mediate
these morphological changes have also been investigated. C3G associates
with cytoskeletal fraction of cells and its expression induces stabilization
of microtubules and inhibits cell motility.
2. Materials and methods
2.1. Cell culture, transfections and treatments
MDA-MB-231, HEK 293T, MCF-7, MDA-MB-453, BT549 and HeLa
cells were obtained from ATCC and grown in DMEM containing 10%
FCS (CDMEM) in a humidiﬁed incubator maintaining 5% CO2. MDA-
MB-231 cells were also obtained from an alternate source (UCLA) to
test whether observations made were speciﬁc to a particular stock.
Transfections were performed using lipofectamine-Plus reagent from
Invitrogen as per manufacturer's instructions. LiCl (50 mM) and BIO
(5 μM) (Calbiochem) treatment was given by adding to cells in
CDMEM6 h after transfection for a period of 24 h. Cells were subjected
to cytochalasin D (Cyto D) (0.2 μg/ml) or nocodazole (NOC) (1 μg/ml)
for a period of 4 h prior to ﬁxation to disrupt microﬁlaments and
microtubules, respectively. Microtubule stability assaywas performed
as described in Bosc et al. with slight modiﬁcation [36]. Cells were
treated with 5 μg/ml nocodazole for 30 min prior to ﬁxation.
Nocodazole, cytochalasin D and the MAPK inhibitors were from
Calbiochem.
Cell fractionation for preparation of cytoskeletal fractions was
carried out essentially as described by Nam et al. [37]. Cells were lysed
by suspending in ice cold buffer (50 mMTris pH 7.4, 10 mMKCl, 1 mM
MgCl2, 1 mM EGTA, 2 mM Na2VO4, 1 mM PMSF, protease inhibitors
and 0.5% triton X-100) and incubated on ice for 10 min followed by
centrifugation at 15,000g for 30 min at 4 °C. The supernatant was
collected as triton soluble fraction. The pellet, containing the triton
insoluble fraction, was washed with buffer without detergent. The
fractions were suspended in SDS sample buffer.
2.2. Plasmids and antibodies
C3G and C3G deletion constructs have been described earlier
[16,17]. TC10 T31N-HA has been described [32]. DnRac1N17myc,
DnRhoAN19myc, DnCdc42N17myc and constitutively active Rap1
(CA-Rap1), HA-Rap1A-Q63E, were kindly provided by Dr Jean de
Gunzburg. GFP-RapGAP was kindly provided by Dr Patrick Casey. GFP
construct was from Clontech. GFP-C3G construct was made by
excising out C3G form PCDNA3 using Hind III and Xho1 and cloning
it into the Hind III and Sal1 sites of GFPN3 vector. GFP-Optineurin has
been described [38]. Myc tagged full length β-catenin expression
vector was kindly provided by Prof. Marian Waterman. DnR-Ras
T43N-GFP was gifted by Dr. John Peranen. CDK2, C3G, β-catenin,
α-tubulin, HA, calnexin, vimentin and myc antibodies were from
Santa Cruz. Acetylated tubulin (Ac-tub) and GAPDH antibodies were
from Sigma and Millipore, respectively. Rhodamine phalloidin and
Oregon Green phalloidin were from Molecular Probes. C9 antibody,
which detects over expressed C3G, was raised in our laboratory [17].
2.3. Western blotting, immunoﬂuorescence, imaging and quantiﬁcation
of NLE
In all experiments cells were processed for lysate preparation or
immunoﬂuorescence after 30 h of transfection. Western blotting and
immunoﬂuorescence were performed as described earlier [17].
Immunoﬂuorescence co-staining for two antigens was performed by
sequential incubation of primary and corresponding secondary
antibodies. Cy3 or Alexa 488 coupled secondary antibodies wereused to detect expression. For methanol ﬁxation, cells were washed
once with PBS and incubated with pre-cooled methanol for 7 min at
−20 °C. After the incubation, cells were washed 3 times with PBS
before blocking for performing immunoﬂuorescence. Images were
taken on Carl Zeiss Apotome with Axioimager Z1 upright microscope
or Leica TCS SP-5 AOBS confocal microscope and analyzed by
Axiovision 4.4 or Leica Application Suite (LAS), respectively. All
images were captured from a single experiment using similar
parameters. Quantitation of NLEs was performed by examining the
cells using a 40× objective of an Olympus ﬂuorescent microscope.
Cells positive for expression of various antigens were examined for
the presence of cellular extensions greater than 2 cell diameters. Cells
stained for F-actin were used to quantitate process formation in non-
expressing cells. A minimum of 200 expressing cells were counted on
each coverslip. Data was averaged from 3 independent experiments
carried out on duplicate coverslips and represented as percentage of
cells showing extensions among antigen expressing cells. Statistical
signiﬁcance was determined using Student's t test.
2.4. Live cell imaging and tracking of cells
For live cell imaging MDA-MB-231 cells were transfected with
GFP-C3G and after 12–16 h of transfection were subjected to imaging
using Carl Zeiss LSM5 live. Imageswere taken after every 20min for a
period of 24 h and analyzed using LSM 5 image examiner and Meta
Morph Version 6.1r0 software was used for tracking the movement
of individual cells in the time frame images. For calculating average
speed, cells were tracked for either a period of 24 h or till the time
they divided or left the ﬁeld of view. For showing the paths traced,
cells were tracked for a period of 6 h and only those cells were
taken into consideration which neither divided nor moved out of the
ﬁeld of view. Student's t test was performed to test the statistical
signiﬁcance of the difference in the average speeds of two cell
populations.
3. Results
3.1. C3G expression induces neurite-like extensions in aggressive breast
cancer cells
The ability of C3G to induce morphological changes in non-neuronal
human cell lines was examined by transient overexpression for 30 h.
Upon examination of C3G expression by indirect immunoﬂuorescence it
was observed that C3G expressingMDA-MB-231 andBT549 cells showed
dramatic changes in cell morphology with two or more cytoplasmic
extensions that resembled neurite outgrowths (Fig. 1A). C3G was
distributed into the cellular processes and therefore these extensions
could be easily observed. These extensions very often ranged from 50 to
200 μm. The cell body appeared rounded and smaller, compared to cells
that did not express C3G. Other cell types like MCF7, HeLa, HEK293T, or
MDA-MB-453 did not showNLEs upon C3G expression, even though C3G
could be expressed at high levels in these cells (Fig. 1A and B). In some of
these cells, C3G expression has been shown to induce ﬁlopodia formation
[17]. Expression of GFP did not result in formation of long processes in
either MDA-MB-231 or BT549 cells, while about 40% of C3G expressing
cells showed dramatic morphological changes at 30 h of expression
(Fig. 1C and D and Supplementary Fig. 1). Supplementary Fig. 1 shows
representative low magniﬁcation images indicating the extent of NLE
formation in C3G expressing MDA-MB-231 and BT549 cells. Short
extensions of 5–10 μm length were seen in 2–3% of MDA-MB-231 cells
that did not express C3G. MDA-MB-231 cells procured from a totally
different source also showed similar phenotypic changes upon C3G
expression (Supplementary Fig. 1). Expression of optineurin, a protein
knownto induceNLEs inhumanﬁbrosarcomacells [39], alsodidnot cause
any morphological changes in MDA-MB-231 cells (Fig. 1C and D).
Co-staining for F-actin showed that C3G induced processes were rich in
Fig. 1. C3G expression induces neurite-like extensions in MDA-MB-231 and BT549 cells. (A) Various human cell lines as indicated were transiently transfected with C3G expression
plasmid for 30 h and stained with anti-C3G antibodies to visualize expressing cells. Panels show morphology of C3G expressing cells captured using ﬂuorescence microscope ﬁtted
with a CCD camera. Bar, 10 μm. (B) Immunoblot showing expression of C3G in cell lysates upon transfection for 30 h. (C) Quantitation of cells showing NLEs amongMDA-MB-231 and
BT549 cells expressing C3G, GFP or optineurin. Data shows proportion of antigen positive cells showing NLEs depicted as mean±SD obtained by quantitation of cells on duplicate
coverslips from 3 independent experiments.*pb0.001. (D) C3G colocalizes with F-actin in extensions. MDA-MB-231 cells expressing C3G, GFP or GFP-OPTN were costained with
Rhodamine phalloidin to detect F-actin. Panels show morphology of expressing cells captured using a confocal microscope. Bar, 20 μm. Magniﬁed region shows presence of distinct
lateral processes rich in F-actin. Bar, 10 μm. (E) Time lapse images of cells expressing GFP-C3G or GFP captured using a 20× objective at 80 min intervals for a period of 6 h. Imaging
was begun 12 h after transfection. Arrows show the position of the growth cone of the NLEs.
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lateral extensions. Though C3G showed a predominantly cytoplasmic
staining, it showed colocalizationwith F-actin only in the cortical regions,
in the extensions, and in microspikes (Fig. 1D, Supplementary Fig. 1C).
Cells expressing C3G lacked stress ﬁbers as shown earlier in HeLa cells
[17]. Theseprocesses resembledextendingneuritesupon live cell imaging
using expression of a GFP tagged C3G construct. They showed the
presence of a growth cone like end with ﬁlopodia and an increase in
length with time (Fig. 1E).We also determined which domains of C3G were required for the
induction of NLE by overexpressing various deletion constructs of
C3G, ΔC, ΔN and CBR (depicted schematically in Fig. 2A). ΔC lacks the
catalytic domain, ΔN lacks the protein interaction domain and CBR
has the protein interaction domain only. ΔN C3G is known to show
constitutive catalytic activity [19]. It was observed that all three
deletion constructs were partially compromised in their ability to
induce NLEs indicating that functions dependent on both the catalytic
domain and protein interaction domain contribute to inducing
Fig. 2. C3G induces NLEs dependent on both catalytic and protein interaction domains. (A) Schematic diagram showing the various domains in full length C3G and the deletion
constructs. (B) MDA-MB-231 cells were transfected with the various C3G constructs, ﬁxed after 30 h and stained to detect expressing cells. Panels show representative ﬁelds of cells.
Bar, 20 μm. (C) Quantitation of NLE formation induced by the various C3G constructs depicted as mean±SD. (D) Western blots showing expression of C3G and its deletion
constructs. UT, untransfected. *indicates a nonspeciﬁc band.
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induce NLEswas not due to differences in level of expression (Fig. 2D).
Earlier, it has been shown that expression of CBR represses oncogene
mediated transformation just as does full length C3G [29]. ThisFig. 3. NLE formation by C3G is dependent on an intact cytoskeleton. (A) C3G expressing M
nocodazole (NOC) for 4 h prior to ﬁxation. Cells were stained for C3G expression and F-act
pattern in representative ﬁelds. Bar, 20 μm. (B) Quantitation of NLE formation in C3G expredomain is known to function dominantly to inhibit catalytic function
of endogenous C3G [14]. In our study, coexpression of CBR with C3G
did not alter extent of NLE formation induced by C3G alone (data not
shown).DA-MB-231 cells were treated with either 0.2 μg/ml cytochalasin D (Cyto D) or 1 μg/ml
in (upper panels) or α-tubulin (lower panels). Images show morphology and staining
ssing cells treated with Cyto D or NOC. *pb0.001, **pb0.0001.
Fig. 4. C3G expression stabilizes microtubules. (A) C3G transfected cells were stained for C3G expression and Ac-tubulin. Blank panels show cells which were not incubated with
Ac-tubulin primary antibody. (B) C3G transfected cells were either left untreated (UT) or subjected to treatment with NOC (5 μg/ml for 30 min) and stained for C3G and α-tubulin.
Bar, 20 μm. (C) MDA-MB-231 cells were transfected with GFP or GFP-C3G and parallel coverslips ﬁxed using either formaldehyde or methanol. Images show representative ﬁelds of
cells with GFP expression. Bar, 20 μm. (D) Number of GFP expressing cells were quantitated under conditions of formaldehyde andmethanol ﬁxation. Proportion of GFP positive cells
seen upon methanol ﬁxation was represented relative to number of GFP positive cells seen upon formaldehyde ﬁxation as 100%. (E) Presence of C3G in cytoskeletal fraction. Triton
insoluble and soluble fractions were made from MDA-MB-231 cells expressing C3G for 30 h followed by Western blotting to detect the presence of C3G in these fractions. Calnexin
and vimentin were used to determine the purity of triton soluble and cytoskeletal fractions respectively. WCL, whole cell lysate.
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Polymerization of microﬁlaments and microtubules regulates
morphology of most cells. But to what extent each of these
cytoskeletal elements contribute to process formation often varies.
The dependence of C3G to induce processes on intact microﬁlaments
and microtubules was tested by treatment of transfected cells with
either cytochalasin D (Cyto D) or nocodazole (NOC), agents that
disrupt actin ﬁlaments and microtubules (MTs), respectively. Cells
expressing C3G were treated with Cyto D or NOC for 4 h prior to
ﬁxation (conditions known to disrupt actin and tubulin structures)
and stained for C3G and F-actin or C3G and α-tubulin, respectively.
C3G induced extensions showed distinct α-tubulin bundles in the
shafts of untreated cells. Treatment resulted in loss of organized
microﬁlaments and microtubules as shown in Fig. 3A. It was observed
that both agents caused a decrease in number of C3G expressing cells
with NLEs (Fig. 3A and B).
Long NLEs are known to be associated with MT rearrangement.
C3G transfected MDA-MB-231 cells were stained for C3G expression
and acetylated-tubulin (Ac-tubulin), a marker for stabilized micro-
tubules [40]. It was observed that C3G induced extensions showed
prominent staining for Ac-tubulin, whereas weak staining was seen in
untransfected cells (Fig. 4A). The ability of C3G to affect microtubule
dynamics was also examined in a stability assay which monitors
nocodazole resistance as an indicator of stable microtubules [36]. C3G
transfected cells were treated with 5 μg/ml NOC for 30 min beforeFig. 5. C3G induced NLEs are dependent on Rap, Rac and Cdc42 function. MDA-MB-231 ce
indicated. Bar, 20 μm. Representative ﬁelds of cells are shown in A and B and quantitationbeing processed for indirect immunoﬂuorescence using antibodies
against C3G and α-tubulin. It was observed that while MTs were
totally disrupted with total loss of α-tubulin staining in untransfected
cells, those expressing C3G retained staining for MT (Fig. 4B).
α-Tubulin staining was seen even in C3G expressing cells that lacked
NLEs, though not equally prominent. These results indicated that C3G
expression has a stabilizing effect on microtubules.
Colocalization of C3G with actin and tubulin in cellular extensions
and its ability to alter their dynamics indicated that C3G may be
binding to cytoskeletal elements in the cell. This was examined by
testing for resistance to methanol ﬁxation, which is known to
permeabilize cells and release cytosolic proteins while formaldehyde
ﬁxation preserves cytosolic proteins [41,42]. MDA-MB-231 cells were
transfected with either GFP or GFP-C3G on parallel coverslips and
ﬁxed using formaldehyde or methanol. Cells were scored for
proportion of GFP positive cells retained upon methanol ﬁxation
relative to proportion seen upon formaldehyde ﬁxation. It was
observed that only about 20% of GFP expressing cells were retained
upon methanol ﬁxation, whereas majority of GFP-C3G expressing
cells were retained (Fig. 4C and D). These results indicated that C3G
tagged GFP is associated with cellular structures while GFP is
primarily cytosolic.
Association of C3G with cytoskeletal elements was also determined
by fractionation ofMDA-MB-231 cells expressing C3G. A fraction of C3G
was found in the triton insoluble fraction, which essentially comprises
cytoskeletal components like vimentin (Fig. 4E). The absence oflls were transfected with C3G along with control plasmid, RAPGAP or Dn GTPases as
of NLEs in C. *pb0.0001.
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which was present exclusively in the soluble fraction.
3.3. C3G induced NLEs dependent on Rap, Rac and Cdc42
To determine the mechanism by which C3G induces NLEs, the
involvement of various signaling effectors known to play a role in
cytoskeletal reorganization and neurite growth was examined. Rho
family GTPases RhoA, Rac1 and Cdc42 have been primarily implicated
in actin reorganization responsible for morphological changes in cells
[43]. Their role in C3G induced NLE formation was examined by
coexpressing dominant negative (Dn) myc-tagged constructs, which
have earlier been used to disrupt the function of endogenous RhoA,
Rac1 and Cdc42 [44]. Quantitation of NLEs in cells coexpressing C3G
with dominant negative forms of Rho, Rac or Cdc42 showed that C3G
induced processes were signiﬁcantly reduced in cells expressing Dn
Rac and Dn Cdc42, but not Dn RhoA (Fig. 5A and C). Expression of
dominant negative constructs of Rac and Cdc42 alone (in the absence
of C3G) did not have an effect on cell morphology, whereas expression
of Dn RhoA alone showed a signiﬁcant overall increase in NLE
formation compared to GFP (data not shown), suggesting that
inhibition of endogenous RhoA activity enables actin reorganization
for NLE formation. NLE formation induced by ΔC-C3G and CBR was
inhibited signiﬁcantly by Dn Cdc42 and Dn Rac, indicating that the
protein interaction domain of C3G signals to cytoskeletal changes
dependent on Cdc42 and Rac (Supplementary Fig 2A, and data not
shown). Rap1, TC10 and R-Ras are known targets/effectors of C3G
[5–7]. Since C3G catalytic activity appeared to contribute to its ability
to induce extensions, we determined which of these molecules were
involved in signaling downstream of C3G by coexpressing Dn TC10,
Dn R-Ras and Rap-GAP, a molecule that inhibits Rap activation. It was
seen that only Rap-GAP coexpression inhibited NLE formation
partially indicating that Rap function contributed to C3G induced
NLE formation (Fig. 5B and C). Lack of signiﬁcant effect upon
coexpressing Dn R-Ras or Dn TC10 suggested that they are not
effective in inhibiting C3G mediated downstream signaling to
cytoskeletal reorganization. Rap-GAP coexpression did not inhibit
NLE formation induced by ΔC-C3G or CBR (data not shown),
indicating that the protein interaction domain of C3G does not trigger
Rap activation (Supplementary Fig. 2A). Expression of CA-Rap1 alone
did not induce NLE formation, nor did it enhance NLEs formed by
ΔC-C3G (Supplementary Fig. 2B).
Rab8, a small GTPase involved in vesicle trafﬁc has been shown to
induce NLEs upon expression of a constitutively active isoform in
HT-1080 cells [39]. To test whether Rab8 activation was involved
downstream of C3G in causing cellular extensions, a dominant negative
variant was coexpressed. It was observed that Dn Rab8 did not repress
C3G induced NLE formation; (Fig. 5A and C) nor did the expression of
constitutively active Rab8 induce processes in MDA-MB-231 cells (data
not shown). MAP kinases have been implicated in signaling to MT
dynamics via phosphorylation of MT associated proteins. To investigate
their involvement as mediators in C3G induced NLEs, C3G transfected
cells were treated with inhibitors speciﬁcally for MAPK (PD 98059) or
p38 (SB 203580) for 24 h and their effect on cell morphology was
examined. MAPK inhibition had no effect on C3G induced process
formation (Supplementary Fig. 3).
3.4. C3G expression suppresses cellular β-catenin levels in MDA-MB-231
Signaling involving APC and β-catenin are known effectors of
cytoskeletal remodeling [45]. The consequence of C3G expression on
cellularβ-catenin levelswas examined inMCF-7, HEK 293,MDA-MB-231
and BT549 cells. It was observed that though C3G overexpression was
comparable, cellular β-catenin levels were signiﬁcantly reduced only in
MDA-MB-231 and BT549 cells upon C3G expression (Fig. 6A). Down-
regulation of β-catenin levels by C3G appears to be mediated throughRap1 activation, since expression of constitutively active Rap1 also
resulted in repression of β-catenin levels (Supplementary Fig. 4).
Expression of the protein interaction domain of C3G(CBR) did not alter
cellular β-catenin levels. To test whether reduced β-catenin levels were
responsible for the morphological changes seen, C3G expressing cells
were treatedwith LiCl or BIO, inhibitors of GSK3-β. This treatment results
in stabilization ofβ-catenin and increase in cellular levels. Itwas observed
that C3G inducedNLEswere signiﬁcantly reduced under these conditions
(Fig. 6B and C). Treatment with LiCl did not affect C3G levels, but showed
an increase in β-catenin as expected (Fig. 6D). C3G-induced repression of
cellular β-catenin was not seen upon LiCl treatment, suggesting that C3G
may be affecting β-catenin levels through regulation of GSK-3β. To
conﬁrm that high β-catenin levels repress NLE formation, β-catenin
expression vector was co-transfected with C3G and NLE formation
quantitated among coexpressing cells. Fig. 6E shows reduction in NLE
formation due to β-catenin coexpression.
3.5. C3G expression inhibits motility of MDA-MB-231 cells
Since formation of NLEs involves cytoskeletal changes and C3G
expression results in loss of stress ﬁbers, the consequence of C3G
expression on cell motility was examined by digital time-lapse
photomicrography. Cells transfected with GFP or GFP-C3G for 12 h
were examined for migration for a 24 h period and total distance
compared between GFP positive and negative cells. Cells at sparse
density were ﬁlmed at 20 min intervals and cell trajectories traced
using Meta Morph version 6.10 software (Fig. 7A). While GFP
expressing cells or untransfected cells showed an average speed of
17.8 and 18.2 μm/h respectively, GFP-C3G expressing cells moved at
an average speed of 8.7 μm/h indicating that C3G expression reduces
cell motility (Fig. 7B). C3G expressing cells, with or without processes,
showed similarmotility, suggesting that reducedmotility is not due to
extension formation.
4. Discussion
This study demonstrates the formation of long processes speciﬁcally
in highly invasive breast cancer cell lines upon enhancing C3G levels
through exogenous expression. These structures are formed through
rearrangementof actin cytoskeleton andmicrotubule network, enabling
bundle formation required for elongation of long cytoplasmic exten-
sions. Accumulation of Ac-tubulin in C3G induced extensions of MDA-
MB-231 cells is similar to that seen in neurites formed in IMR-32
neuroblastoma cells upon C3G expression except that long extensions
formed by 24 h inMDA-MB-231 cells unlike in the case of extensions in
neuronal cells which were evident only 48–72 h after transfection [32].
Morphological similarity complemented by similarity in MT and
microﬁlament bundling suggested that they could be called NLEs [46].
The molecular mechanisms involved in neural process initiation have
not been well elucidated. Our results show that C3G associates with
cytoskeletal components in MDA-MB-231 cells and therefore suggest
that C3G can function to cause actin andmicrotubule reorganization and
morphological changes required during the complex process of
neuronal differentiation, in certain non-neuronal cells.
Outgrowth of neurite-like processes in response to certain
extracellular stimuli has been shown in other non-neuronal cells
[47]. Expression of neuronal proteins like drebrin or Neuro-p24
results in formation of NLE in ﬁbroblasts [48,49]. C3G signaling has
been implicated earlier in cell morphology as expression of Myr-CHAT
induced cell protrusions with branched morphology in NIH3T3 cells
dependent on Crk-C3G-Rap1 pathway [50]. p120 catenin expression
resulted in Rac1 dependent formation of dendritic extensions in
MDA-MB-231 and NIH 3T3 cells [51]. The Cas family docking protein,
HEF1, induced NLEs in MCF-7 cells dependent on Rac and Cdc 42 [52].
ZNRF1 expression causes neurite-like morphological changes in non-
neuronal cells [53]. These studies have not described cell type
Fig. 7. C3G expression inhibits cell motility. (A) MDA-MB-231 cells transfected with
GFP-C3G were subjected to live cell imaging after 16 h and imaged every 20 min for a
total period of 24 h. Panels show paths of non-expressing cells and GFP-C3G expressing
cells captured for a period of 6 h. Bar, 50 μm. (B) Average speed of non-expressing cells,
GFP or GFP-C3G expressing cells tracked for a period of 24 h. Data was averaged using
multiple cells from two independent experiments. *pb0.0001.
Fig. 6. C3G expression downregulates cellular β-catenin in MDA-MB-231 and BT549 cells. (A) MCF-7, MDA-MB-231, HEK293T and BT549 cells were transiently transfected with C3G
expression plasmid (for 30 h) and cell lysates subjected to Western blotting for C3G, β-catenin and CDK2 (loading control). Values indicate relative levels of β-catenin in C3G
expressing cells compared to non-expressing cells. (B) MDA-MB-231 cells expressing C3G were left untreated (UT) or treated with LiCl or BIO and examined for effect on cell
morphology. (C) Effect of LiCl on extent of NLE formation by C3G in MDA-MB-231 and BT549 cells. *pb0.01. (D) Lysates of MDA-MB-231 cells treated as in (C) were subjected to
Western blotting for C3G, β-catenin and CDK2. (E) β-catenin coexpression inhibits C3G induced NLE formation. Quantitation of NLE formation in MDA-MB-231 cells expressing C3G
along with control or β-catenin expressing plasmids. *pb0.001.
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morphological changes only in aggressive breast cancer cells.
Rac and Cdc42 are known mediators of actin based changes at the
cell membrane such as lamellipodia and ﬁlopodia formation. Our
results show that C3G induces NLE by engaging the functions of Rac
and Cdc42. This function is mediated by the protein interaction
domain of C3G. RhoA activity, which functions in organizing
intracellular stress ﬁbers, did not contribute to signaling downstream
of C3G. Rho has been described as a neurite inhibitory GTPase and Rac,
a neurite promoting GTPase [51]. As shown earlier [46] in our
experiments too, RhoA inhibition by a dominant negative construct in
the absence of C3G caused NLE formation, indicating that C3G may
also function by inhibiting RhoA to cause cytoskeletal reorganization.
C3G expression causes loss of stress ﬁbers, which are required for
formation of mature focal contacts, required for normal motility of
cells [54]. Therefore defective motility in C3G expressing cells may be
due to defects in formation of cell substratum adhesions. These results
are also in agreement with ﬁndings showing enhanced motility of
ﬁbroblasts from C3G deﬁcient mouse embryos [33]. Deregulated
expression of C3G therefore has implications in suppressingmigration
in this cell line derived from an invasive tumor.
CA-Rap1 did not result in NLE formation in these cells, though it
could signal to reduction in β-catenin levels, indicating that multiple
effectors may be engaged by C3G to bring about these morphological
changes. Rap1 has recently been described as a negative regulator of
β-catenin in endothelial cells [55]. Our results using the deletion
constructs showed that protein interaction domain, as well as
catalytic domain, is compromised for NLE formation, indicating that
various C3G domains have the ability of signaling to cytoskeletal
changes. The fact that no additive effect was seen upon coexpression
464 K. Dayma, V. Radha / Biochimica et Biophysica Acta 1813 (2011) 456–465of CBR with C3Gmay be due to insufﬁciency of endogenous molecules
engaged by C3G and CBR in signaling to cytoskeletal remodeling.
Expression of CA- Rap1 along with protein interaction domain of C3G
did not enhance NLE formation to the same extent seen upon
expressing full length C3G, indicating that Rap activation state
turnover is important for affecting NLE formation. Activation of
Rap1 at distinct subcellular locales may also be important for NLE
formation, and difference in location of CA-Rap1 compared to that of
C3G may be responsible for the inability of CA-Rap1 to induce NLE
formation. The adaptor protein CrkII is known to constitutively
associate with C3G and aid in its membrane targeting [18]. But
expression of Dn CrkII constructs did not affect C3G induced
morphological changes, indicating that CrkII does not contribute to
causing NLEs formed by C3G.
C3G induced neurite-like process formation correlated with a
reduction in cellular β-catenin levels, with forced stabilization of
endogenous β-catenin by GSK-3β inhibition or exogenous expression
repressing these morphological changes. β-Catenin functions in
regulating cell proliferation and metastasis by signaling to actin
cytoskeleton changes [54] and β-catenin mediated signaling has been
shown to negatively regulate retinal neurite extension [56]. Reduced
β-catenin has also been shown to increase extensions in HeLa cells
[57]. Reduction in β-catenin protein expression is associated with
reduced growth in MDA-MB-231 cells [58]. C3G deﬁcient neuroe-
pithelial cells accumulate β-catenin and fail to exit cell cycle in vivo
[35]. Effect of C3G on β-catenin levels is cell type speciﬁc and
correlated with NLE formation, since destabilization was not seen in
either MCF-7 or HEK-293 cells. Our results are consistent with the
suggestion that C3G induces NLE in cells through multiple mecha-
nisms involving properties such as (1) association with cytoskeleton,
(2) signaling to activate Rho family GTPases, Cdc42 and Rac mediated
by its protein interaction domain, (3) activation of Rap, and (4)
repression of β-catenin levels. Ability of C3G to signal to both actin
microﬁlaments and microtubules in the cell by engaging multiple
effectors like Rac, Cdc42, Rap and β-catenin is indicative of its role as
an upstream regulator modulating multiple signaling pathways
required for cell shape changes.
MDA-MB-231, breast cancer cells derived from a metastatic
pleural effusion, have been described as a highly dedifferentiated
mesenchymal like cell line. BT549 cells derived from a breast and
invasive ductal tumor has been described to have mesenchymal
properties. These two cell lines are models for more aggressive
metastatic disease [59]. It is not totally evident as to why C3G induces
dramatic changes in morphology only in highly metastatic cells.
Invasive and aggressive breast cancer cells are known to have unique
molecular signatures [60] and our results are indicative of unique
properties possessed by cell lines derived from highly invasive breast
cancer cells. Recent studies have shown that MDA-MB-231 cells
express neuronal and vascular markers [61,62]. One recent hypothesis
suggests that tumors arise from cells which retain pluripotency and
can therefore be induced to differentiate into distinct lineages [63].
Some breast cancer cells also show lineage inﬁdelity [64]. These cells
may therefore serve as a model to study neuronal differentiation of
mesenchymal cells.
5. Conclusions
Findings from the present study show that C3G deregulation
through overexpression remodels microﬁlaments and microtubules
to induce a neuronal phenotype, and inhibit motility of highly
invasive breast cancer cells. MT stabilization and NLE formation
represent previously undescribed functions of C3G. C3G induced NLE
formation was dependent on Rho family GTPases and destabilization
of β-catenin. This study advances our understanding of how signaling
components regulate the cytoskeleton for causing the extensive
plasticity involved in formation of NLEs. It raises the possibility oftrans-differentiating easily accessible breast cancer cells to adopt
neuronal morphology for enabling an understanding of complex
signaling events required for acquiring a neuronal phenotype. Our
ﬁndings also suggest that through suppression of cell motility, C3G
overexpression could help in inhibiting metastatic properties of
invasive breast cancer cells.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamcr.2011.01.004.
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